BRIEF published on 06/13/2024 at 18:05, 1 year 5 months ago 2023-2024 annual results: Oeneo maintains a current operating margin of 14% Annual Results Operating Margin Oeneo Viticulture
PRESS RELEASE published on 06/13/2024 at 18:00, 1 year 5 months ago 2023-2024 ANNUAL RESULTS : RECURRING OPERATING MARGIN OF 14.0%, IN LINE WITH EXPECTATIONS - WELL-MANAGED CASH FLOW Oeneo Group's 2023-2024 financial year ended with a turnover of €305.7 million, down 12.2%. The company remains resilient with a recurring operating margin of 14.0% Financial Year Turnover Resilient Oeneo Group Recurring Operating Margin
BRIEF published on 05/13/2024 at 18:05, 1 year 6 months ago Oeneo Annual Financial Review: An Exercise in Economic Resilience Turnover 2023-2024 Oeneo Corking Breeding
PRESS RELEASE published on 05/13/2024 at 18:00, 1 year 6 months ago 2023-2024 ANNUAL TURNOVER: EUR 305.7 MILLION - TREND IMPROVEMENT IN FOURTH QUARTER Oeneo Group reports €80.1 million turnover in Q4 2023-2024, with 12% decrease for the full year. Closures division sees growth in Diam closure sales Turnover Oeneo Group Q4 2023-2024 Closures Division Diam Closure
Published on 12/05/2025 at 02:35, 3 hours 51 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 5 hours 26 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 7 hours 21 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 7 hours 26 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 2 hours 56 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 6 hours 36 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 10 hours 1 minute ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 10 hours 11 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 11 hours 16 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:00, 12 hours 26 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 12 hours 41 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 12 hours 42 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 23 hours 25 minutes ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 12 hours ago Declaration of voting rights at the end of November 2025
